The identification and management of interstitial lung disease in ...

6.3 Treatment for PF-ILD?? The anti-fibrotic agents might prevent disease progression of RA-ILD. Nintedanib is an intracellular inhibitor of tyrosine kinases and ...







Cyclophosphamide for interstitial lung disease-associated acute ...
Introduction: This pooled analysis of nine phase I and II trastuzumab deruxtecan (T-DXd) monotherapy studies.                                                
Diagnosis and Management of Fibrotic Interstitial Lung Disease
Commonly used agents include cyclophosphamide (CYC), mycophenolate mofetil (MMF), rituximab (RTX), azathioprine (AZA), tocilizumab, methotrexate and prednisone.
a novel diagnostic tool for interstitial lung disease
For IPF, two antifibrotic drugs (nintedanib and pirfenidone) are available that slow down disease progression. More recently, antifibrotic drugs have also ...



Autres Cours:

PH-ILD - tyvaso